These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
441 related items for PubMed ID: 29119706
1. Insights on efficacious doses of PAMORAs for patients on chronic opioid therapy or opioid-naïve patients. van Malderen K, Halawi H, Camilleri M. Neurogastroenterol Motil; 2018 May; 30(5):e13250. PubMed ID: 29119706 [Abstract] [Full Text] [Related]
2. Naloxegol: A Novel Therapy in the Management of Opioid-Induced Constipation. Jones R, Prommer E, Backstedt D. Am J Hosp Palliat Care; 2016 Nov; 33(9):875-880. PubMed ID: 26150678 [Abstract] [Full Text] [Related]
3. Pharmacological Profile of Naldemedine, a Peripherally Acting μ-Opioid Receptor Antagonist: Comparison with Naloxone and Naloxegol. Kanemasa T, Koike K, Takase K, Arai T, Nakamura A, Morioka Y, Hasegawa M. J Pharmacol Exp Ther; 2020 Jun; 373(3):438-444. PubMed ID: 32169839 [Abstract] [Full Text] [Related]
4. Evaluating naloxegol for the treatment of opioid-induced constipation. Daniali M, Nikfar S, Abdollahi M. Expert Opin Pharmacother; 2020 Jun; 21(8):883-891. PubMed ID: 32129103 [Abstract] [Full Text] [Related]
5. Novel Oral Therapies for Opioid-induced Bowel Dysfunction in Patients with Chronic Noncancer Pain. Holder RM, Rhee D. Pharmacotherapy; 2016 Mar; 36(3):287-99. PubMed ID: 26945548 [Abstract] [Full Text] [Related]
6. Cardiovascular Safety of the Selective μ-Opioid Receptor Antagonist Naloxegol: A Novel Therapy for Opioid-Induced Constipation. White WB, Kowey P, Diva U, Sostek M, Tummala R. J Cardiovasc Pharmacol Ther; 2018 Jul; 23(4):309-317. PubMed ID: 29504415 [Abstract] [Full Text] [Related]
7. Efficacy of Treatments for Opioid-Induced Constipation: Systematic Review and Meta-analysis. Nee J, Zakari M, Sugarman MA, Whelan J, Hirsch W, Sultan S, Ballou S, Iturrino J, Lembo A. Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1569-1584.e2. PubMed ID: 29374616 [Abstract] [Full Text] [Related]
12. The Use of Peripheral μ-Opioid Receptor Antagonists (PAMORA) in the Management of Opioid-Induced Constipation: An Update on Their Efficacy and Safety. Pergolizzi JV, Christo PJ, LeQuang JA, Magnusson P. Drug Des Devel Ther; 2020 Oct; 14():1009-1025. PubMed ID: 32210534 [Abstract] [Full Text] [Related]
19. Efficacy and Safety of Peripherally Acting Mu-Opioid Receptor Antagonists for the Treatment of Opioid-Induced Constipation: A Bayesian Network Meta-analysis. Ouyang R, Li Z, Huang S, Liu J, Huang J. Pain Med; 2020 Nov 01; 21(11):3224-3232. PubMed ID: 32488259 [Abstract] [Full Text] [Related]
20. Naloxegol for the treatment of opioid-induced constipation. Tack J, Corsetti M. Expert Rev Gastroenterol Hepatol; 2014 Nov 01; 8(8):855-61. PubMed ID: 25220391 [Abstract] [Full Text] [Related] Page: [Next] [New Search]